loading page

Model-Informed Drug Approach to Recommend Therapeutic Burosumab Dosing Regimens for Pediatric and Adult Patients with Tumor-Induced Osteomalacia
  • +6
  • Matthew Hruska,
  • Lamia Sid-Otmane,
  • Nathalie Gosselin,
  • Emilia Quattrocchi,
  • Sun Ku Lee,
  • Mary Ann Mascelli,
  • Krina Mehta,
  • Suzanne Jan de Beur,
  • Douglas Marsteller
Matthew Hruska
Kyowa Kirin Co Ltd

Corresponding Author:[email protected]

Author Profile
Lamia Sid-Otmane
Certara Canada Corporation
Author Profile
Nathalie Gosselin
Pharsight, A Certara Company
Author Profile
Emilia Quattrocchi
Kyowa Kirin Ltd
Author Profile
Sun Ku Lee
Ultragenyx Pharmaceutical Inc
Author Profile
Mary Ann Mascelli
Chinook Therapeutics Inc
Author Profile
Krina Mehta
Kyowa Kirin Co Ltd
Author Profile
Suzanne Jan de Beur
University of Virginia
Author Profile
Douglas Marsteller
Kyowa Kirin Co Ltd
Author Profile